Dr Bettina Werle
Bettina Werle has over 20 years’ experience in creating innovative biotherapeutic solutions for vaccine, diagnostic and therapeutic applications in the field of immunology and infectious diseases, with a global vision from design to development.
With a PhD in cellular and molecular biology and biochemistry from the University of Burgundy, Bettina Werle evolved in various environments from academia to pharmaceutical industries.
She has the ability to enhance the value of research projects via patents and publications and has years of experience working in an R&D setting. Most recently, she worked as CSO and R&D director at Magnisense where she was responsible for developing a new competitive and innovative R&D strategy.
“I am passionate about leading and motivating the teams I work with; developing innovative projects within a company. With my experience in R&D, I take pride in being able to build collaborative networks with internal and external stakeholders; identify and develop innovative technologies that will create business value. I am delighted to join the team at Tollys during this interesting period of growth for the company.”
Cutting-Edge Cancer Immunotherapy
60F avenue Rockefeller
69008 Lyon, FRANCE